Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri®) Dosing: NOVA Phase IIIb Extension Study (Part 2).
Journal: Neurology and therapy
Published: April 03, 2024
An Approach to Myopathy for the Primary Care Clinician.
Journal: The American journal of medicine
Published: October 02, 2017
Showing 1-3 of 3
Last Updated: 09/26/2026